Senter PD - Search Results

1

Development and activities of a new melphalan prodrug designed for tumor-selective activation.

Kerr DE, Li Z, Siemers NO, Senter PD, Vrudhula VM. Kerr DE, et al. Among authors: senter pd. Bioconjug Chem. 1998 Mar-Apr;9(2):255-9. doi: 10.1021/bc970163l. Bioconjug Chem. 1998. PMID: 9548542

2

Reductively activated disulfide prodrugs of paclitaxel.

Vrudhula VM, MacMaster JF, Li Z, Kerr DE, Senter PD. Vrudhula VM, et al. Among authors: senter pd. Bioorg Med Chem Lett. 2002 Dec 16;12(24):3591-4. doi: 10.1016/s0960-894x(02)00784-9. Bioorg Med Chem Lett. 2002. PMID: 12443783

3

Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion protein.

Vrudhula VM, Kerr DE, Siemers NO, Dubowchik GM, Senter PD. Vrudhula VM, et al. Among authors: senter pd. Bioorg Med Chem Lett. 2003 Feb 10;13(3):539-42. doi: 10.1016/s0960-894x(02)00935-6. Bioorg Med Chem Lett. 2003. PMID: 12565967

4

Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug.

Svensson HP, Kadow JF, Vrudhula VM, Wallace PM, Senter PD. Svensson HP, et al. Among authors: senter pd. Bioconjug Chem. 1992 Mar-Apr;3(2):176-81. doi: 10.1021/bc00014a013. Bioconjug Chem. 1992. PMID: 1515470

5

Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers.

Senter PD, Svensson HP, Schreiber GJ, Rodriguez JL, Vrudhula VM. Senter PD, et al. Bioconjug Chem. 1995 Jul-Aug;6(4):389-94. doi: 10.1021/bc00034a008. Bioconjug Chem. 1995. PMID: 7578358

6

Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

Kerr DE, Schreiber GJ, Vrudhula VM, Svensson HP, Hellström I, Hellström KE, Senter PD. Kerr DE, et al. Among authors: senter pd. Cancer Res. 1995 Aug 15;55(16):3558-63. Cancer Res. 1995. PMID: 7627964

7

Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Senter PD. Vrudhula VM, et al. Among authors: senter pd. J Med Chem. 1995 Apr 14;38(8):1380-5. doi: 10.1021/jm00008a016. J Med Chem. 1995. PMID: 7731023

8

In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.

Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM. Svensson HP, et al. Among authors: senter pd. Cancer Res. 1995 Jun 1;55(11):2357-65. Cancer Res. 1995. PMID: 7757987

9

Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.

Vrudhula VM, Svensson HP, Kennedy KA, Senter PD, Wallace PM. Vrudhula VM, et al. Among authors: senter pd. Bioconjug Chem. 1993 Sep-Oct;4(5):334-40. doi: 10.1021/bc00023a005. Bioconjug Chem. 1993. PMID: 8274516

10

Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate.

Kerr DE, Garrigues US, Wallace PM, Hellström KE, Hellström I, Senter PD. Kerr DE, et al. Among authors: senter pd. Bioconjug Chem. 1993 Sep-Oct;4(5):353-7. doi: 10.1021/bc00023a008. Bioconjug Chem. 1993. PMID: 8274519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters